Catching the Cold

Tracking the genetic diversity and evolution of rhinoviruses can lead to a better understanding of viral evolution, the common cold, and more dangerous infections.

Written byFred Adler
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

© OCEAN/CORBISThe common cold is usually nothing more than a temporary nuisance. Except for people who are highly immunosuppressed or have other serious conditions, colds—most commonly caused by very small RNA viruses known as rhinoviruses—are usually restricted to the cells lining the upper respiratory tract and tend to be limited in duration and symptoms. Nevertheless, with a global population exceeding one billion trillion (1021), rhinoviruses are arguably the most successful rapidly infecting viruses on Earth today.

Despite their abundance, rhinoviruses have been relatively understudied by virologists and largely ignored by epidemiologists and virus modelers. Many mathematical methods for studying virus evolution and spread have provided key insights into the control of epidemics, but these efforts have concentrated on viruses such as HIV and influenza, and cannot be directly applied to the study of rhinoviruses. Unlike these more dangerous viruses, rhinoviruses did not jump recently from other animals to humans. They are human specialists that almost certainly evolved several times from the equally specialized enteroviruses that infect the gut. This means that rhinoviruses are highly adapted to humans, possibly explaining their low virulence—because they have had a chance to evolve efficient ways of spreading to many individuals without harming their hosts—and their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas